Clin Res Cardiol (2021). 10.1007/s00392-021-01933-9

Revival of the Forgotten: Temperature-controlled Ablation of the Pulmonary Veins using the Novel DiamondTemp Ablation System
L. Rottner1, F. Moser1, J. Moser2, R. Schleberger2, M. Lemoine2, P. Münkler2, L. Dinshaw2, P. Kirchhof1, F. Ouyang2, A. Rillig2, A. Metzner2, B. Reissmann2
1Klinik für Kardiologie, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg; 2Klinik für Kardiologie mit Schwerpunkt Elektrophysiologie, Universitäres Herz- und Gefäßzentrum Hamburg GmbH, Hamburg;

Background: Pulmonary vein isolation (PVI) by contiguous, transmural and durable lesions is decisive for ensuring long-term freedom from atrial fibrillation (AF). AF-ablation requires irrigated tip catheters to reduce thromboembolic complications. This precluded temperature-controlled delivery of radiofrequency (RF) energy.

Aim: To evaluate feasibility, acute efficacy and safety of an irrigated, temperature-controlled ablation catheter (DiamondTempTM, Medtronic®, DT) for PVI.

Methods: Consecutive patients with AF underwent PVI using the DT catheter combined with high-power short-duration RF-applications. Ablation settings were 1) a catheter-tip temperature limit of 60°C, 2) a temperature-controlled power of 50 W, and 3) an application duration of 10 sec. Primary endpoint was acute PVI, reassessed after a 30 min waiting period. Secondary endpoints included procedural parameters (catheter-tip temperature of 50°C >3 sec, an impedance drop of 5-10 Ω) and the occurrence of serious adverse events. 

Results: 50 consecutive patients [mean age 6612 years, 38 (76%) female, 24 paroxysmal AF (48%)] were included. Median procedure and left atrial dwell time was 89 [68;107] and 63 [52;79] min. Mean number of RF-applications was 5920 per patient, and mean total RF-duration 146 min. Acute PVI was achieved in all patients. Acute PV reconnection within the waiting period occurred in five patients; all reconnected PVs were successfully re-isolated. One major complication occurred. 

Conclusion: In this study, the DT ablation system demonstrated high acute efficacy and safety for PVI. 


https://dgk.org/kongress_programme/ht2021/P908.htm